COMMONWEALTH EQUITY SERVICES, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 288 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$427
-10.5%
27,596
-9.1%
0.00%0.0%
Q2 2023$477
-16.2%
30,356
-12.2%
0.00%0.0%
Q1 2023$569
+4.0%
34,576
-1.5%
0.00%0.0%
Q4 2022$547
-99.9%
35,106
-46.7%
0.00%
-50.0%
Q3 2022$854,000
-10.5%
65,857
-3.1%
0.00%0.0%
Q2 2022$954,000
-12.4%
67,990
-10.6%
0.00%0.0%
Q1 2022$1,089,000
+0.9%
76,071
-3.9%
0.00%0.0%
Q4 2021$1,079,000
-45.6%
79,174
-34.6%
0.00%
-60.0%
Q3 2021$1,983,000
-30.7%
121,067
-28.8%
0.01%
-28.6%
Q2 2021$2,862,000
+12.9%
170,096
+22.5%
0.01%0.0%
Q1 2021$2,534,000
+43.4%
138,807
+42.9%
0.01%
+40.0%
Q4 2020$1,767,000
+265.8%
97,133
+258.5%
0.01%
+150.0%
Q3 2020$483,000
-10.9%
27,094
-10.4%
0.00%0.0%
Q2 2020$542,000
+12.7%
30,246
-4.7%
0.00%0.0%
Q1 2020$481,000
-31.7%
31,736
-11.1%
0.00%
-33.3%
Q4 2019$704,000
+20.8%
35,695
+5.2%
0.00%
+50.0%
Q3 2019$583,000
+28.7%
33,928
+32.5%
0.00%0.0%
Q2 2019$453,000
-37.4%
25,600
-28.0%
0.00%
-33.3%
Q1 2019$724,00035,5670.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2021
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders